Article
BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma
8 Sept 2023
Abstract excerpt
BACKGROUND: High-risk neuroblastoma is a complex genetic disease that is lethal in more than 50% of patients despite intense multimodal therapy. Through genome-wide association studies (GWAS) and next-generation sequencing, we have identified common single nucleotide polymorphisms and rare, pathogenic or likely pathogenic germline loss-of-function variants in BARD1 enriched in neuroblastoma patients. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
